These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36796299)

  • 1. Advances in the development of phosphodiesterase 7 inhibitors.
    Huang JX; Zhu BL; Xu JP; Zhou ZZ
    Eur J Med Chem; 2023 Mar; 250():115194. PubMed ID: 36796299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Development of Phosphodiesterase-4 Inhibitors.
    Peng T; Qi B; He J; Ke H; Shi J
    J Med Chem; 2020 Oct; 63(19):10594-10617. PubMed ID: 32255344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the development of phosphodiesterase-4 inhibitors.
    Li G; He D; Cai X; Guan W; Zhang Y; Wu JQ; Yao H
    Eur J Med Chem; 2023 Mar; 250():115195. PubMed ID: 36809706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 7(PDE7): A unique drug target for central nervous system diseases.
    Chen Y; Wang H; Wang WZ; Wang D; Skaggs K; Zhang HT
    Neuropharmacology; 2021 Sep; 196():108694. PubMed ID: 34245775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions.
    Szczypka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research.
    Jankowska A; Swierczek A; Chlon-Rzepa G; Pawlowski M; Wyska E
    Curr Med Chem; 2017; 24(7):673-700. PubMed ID: 28093982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase 7 as a therapeutic target - Where are we now?
    Zorn A; Baillie G
    Cell Signal; 2023 Aug; 108():110689. PubMed ID: 37120115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases.
    Martinez A; Gil C
    Expert Opin Ther Pat; 2014 Dec; 24(12):1311-21. PubMed ID: 25284693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis.
    González-García C; Bravo B; Ballester A; Gómez-Pérez R; Eguiluz C; Redondo M; Martínez A; Gil C; Ballester S
    Br J Pharmacol; 2013 Oct; 170(3):602-13. PubMed ID: 23869659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cAMP Phosphodiesterases Act Together to Prevent Premature Oocyte Meiosis and Ovulation.
    Vigone G; Shuhaibar LC; Egbert JR; Uliasz TF; Movsesian MA; Jaffe LA
    Endocrinology; 2018 May; 159(5):2142-2152. PubMed ID: 29608743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A; Jerez MJ; Gil C; Martinez A
    Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia.
    Zhang L; Murray F; Zahno A; Kanter JR; Chou D; Suda R; Fenlon M; Rassenti L; Cottam H; Kipps TJ; Insel PA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19532-7. PubMed ID: 19033455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts.
    Pekkinen M; Ahlström MEB; Riehle U; Huttunen MM; Lamberg-Allardt CJE
    Bone; 2008 Jul; 43(1):84-91. PubMed ID: 18420479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structural analysis, and biological evaluation of thioxoquinazoline derivatives as phosphodiesterase 7 inhibitors.
    Castaño T; Wang H; Campillo NE; Ballester S; González-García C; Hernández J; Pérez C; Cuenca J; Pérez-Castillo A; Martínez A; Huertas O; Gelpí JL; Luque FJ; Ke H; Gil C
    ChemMedChem; 2009 May; 4(5):866-76. PubMed ID: 19350606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders.
    Safavi M; Baeeri M; Abdollahi M
    Expert Opin Drug Discov; 2013 Jun; 8(6):733-51. PubMed ID: 23570245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective inhibition of PDE4 and PDE7 on airway reactivity and cough in healthy and ovalbumin-sensitized guinea pigs.
    Mokry J; Joskova M; Mokra D; Christensen I; Nosalova G
    Adv Exp Med Biol; 2013; 756():57-64. PubMed ID: 22836619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDE4 inhibitors for disease therapy: advances and future perspective.
    Du B; Luo M; Ren C; Zhang J
    Future Med Chem; 2023 Jul; 15(13):1185-1207. PubMed ID: 37470147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement.
    Wei X; Yu G; Shen H; Luo Y; Shang T; Shen R; Xi M; Sun H
    Bioorg Chem; 2023 Jan; 130():106278. PubMed ID: 36413930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.